HBIO HARVARD BIOSCIENCE INC Management Changes 8-K Filing 2024 - Compensation Committee Approval Harvard Bioscience approved the 2024 annual cash incentive plan for its CEO and CFO based on corporate financial objectives.Get access to all SEC 8-K filings of the HARVARD BIOSCIENCE INC